Cepheid is a company that specializes in molecular diagnostic testing. They develop and manufacture a range of tests and systems for detecting and identifying various infectious diseases, genetic disorders, and other medical conditions. Their products include the GeneXpert system, a flexible and scalable platform that provides healthcare professionals with a broad test menu for use in various settings, from core labs to near-patient applications. Cepheid's tests cover a wide range of areas, including respiratory health, hospital-acquired infections, blood virology, women's health, and oncology. The company's goal is to enable access to high-quality diagnostic testing everywhere, and they offer a range of solutions and services to support this aim, including their Global Access program and customized testing options.

Over a decade ago, Cepheid set the standard for innovation in automated molecular diagnostics — and we’ve never looked back. Today, even with the largest installed base of any molecular platform, Cepheid is constantly innovating and evolving its capabilities. The GeneXpert® System has been heralded as game-changing by healthcare leaders across the globe — enabling institutions of any size, from small medical clinics to high-volume reference laboratories and hospitals, to access the speed and accuracy of molecular diagnostics. Cepheid’s growing Xpert® test menu spans multiple clinical applications including healthcare-associated infections, sexual health, critical infectious disease, virology, and oncology.

Critical Infectious Diseases
Sexual Health
Healthcare Associated Infections
Oncology/Genetics